Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05220501 · ClinicalTrials.gov registry record · NA
Optimization of Prostate Biopsy - Micro-Ultrasound Versus MRI
A NA study, sponsored by Sunnybrook Health Sciences Centre.
- Completed
- Registry status
- NA
- Development phase
- 804
- Enrollment target
NCT05220501 is a NA study that has completed, run by Sunnybrook Health Sciences Centre. The registered enrollment target is 804 participants.
The verdict
NCT05220501, a NA study, has completed, sponsored by Sunnybrook Health Sciences Centre.
- COMPLETED
- Registry status
- NA
- Development phase
- 804 participants
- Enrollment target
Study Summary
OPTIMUM is a study designed to compare the ability of ultra-high resolution transrectal micro-ultrasound (microUS) and multiparametric MRI (mpMRI)/US fusion to guide prostate biopsy.
Interventions
- DIAGNOSTIC_TEST Microultrasonography Targeted Biopsy
- DIAGNOSTIC_TEST MRI Targeted Biopsy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 804 participants |
| Start Date | 2021-12-15 |
| Est. Completion | 2024-09-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05220501
The ClinicalTrials.gov registry entry for NCT05220501 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 804 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Sunnybrook Health Sciences Centre, which has 7 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Microultrasonography Targeted Biopsy is the first listed.
NCT05220501 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05220501 about?
NCT05220501 is a clinical study titled "Optimization of Prostate Biopsy - Micro-Ultrasound Versus MRI". OPTIMUM is a study designed to compare the ability of ultra-high resolution transrectal micro-ultrasound (microUS) and multiparametric MRI (mpMRI)/US fusion to guide prostate biopsy.
What is the current status of trial NCT05220501?
This trial is currently completed. It is a NA study. The enrollment target is 804 participants. The study started on 2021-12-15. Estimated completion is 2024-09-06.
What interventions are being tested in trial NCT05220501?
The interventions under investigation include: Microultrasonography Targeted Biopsy (DIAGNOSTIC_TEST), MRI Targeted Biopsy (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT05220501?
This trial is sponsored by Sunnybrook Health Sciences Centre, which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.